11/14/2024 3:53 PM | Nantahala Capital Management, LLC (Filed by) ZEVRA THERAPEUTICS, INC. (Subject) Zevra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/04/2024 1:15 PM | VANGUARD GROUP INC (Filed by) ZEVRA THERAPEUTICS, INC. (Subject) Zevra Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2024 3:46 PM | Watton Corey Michael (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:17 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 3:54 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B5 | |
07/17/2024 4:54 PM | Clifton R. LaDuane (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:39 PM | Anderson Thomas (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/12/2024 3:37 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
07/09/2024 8:23 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:11 PM | Thompson Rahsaan (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/25/2024 4:13 PM | Thompson Rahsaan (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form EFFECT | |
05/15/2024 8:15 PM | Watton Corey Michael (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:18 PM | Calder Douglas W (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:20 PM | FAVORITO TAMARA A (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:28 PM | DIXON WENDY L (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:31 PM | Bode John B (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:05 PM | Anderson Thomas (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:13 PM | Shih Alvin (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 6:54 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 6:49 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024 3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B3 | |
04/10/2024 6:46 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2024 11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form EFFECT | |
04/05/2024 6:39 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form S-3/A | |
04/01/2024 4:27 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 7:28 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 6:34 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 7:24 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 8:39 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/02/2024 8:22 PM | Schafer Joshua (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:13 PM | Guenther Sven (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:14 PM | Mickle Christal M M (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:17 PM | Sangiovanni Timothy J. (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:08 PM | Shih Alvin (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:10 PM | McFarlane Neil F. (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:11 PM | Clifton R. LaDuane (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:13 AM | Shih Alvin (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) ZEVRA THERAPEUTICS, INC. (Subject) Zevra Therapeutics (Subject)
| Form SC 13G | |
01/23/2024 6:37 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
01/08/2024 7:03 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 6:48 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |